13D/13G Filings - Sana Biotechnology Inc. (SANA)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
3:02 pm
Purchase
2021-12-31 13G Sana Biotechnology, Inc.
SANA
Flagship Ventures Fund V, L.P. 34,239,018
18.100%
34,239,018increase
(New Position)
Filing
History
2022-02-10
5:12 pm
Purchase
2021-12-31 13G Sana Biotechnology, Inc.
SANA
ARCH Venture Fund IX, L.P. 44,078,591
23.300%
44,078,591increase
(New Position)
Filing
History
2022-02-09
10:24 am
Sale
2022-02-08 13G Sana Biotechnology, Inc.
SANA
FMR CORP 8,627,851
4.569%
-822,410decrease
(-8.70%)
Filing
History
2022-01-26
07:03 am
Purchase
2021-12-31 13G Sana Biotechnology, Inc.
SANA
BAILLIE GIFFORD & CO 11,262,030
5.960%
11,262,030increase
(New Position)
Filing
History
2021-02-10
09:23 am
Purchase
2021-02-09 13G Sana Biotechnology, Inc.
SANA
FMR CORP 9,450,261
5.390%
9,450,261increase
(New Position)
Filing
History
Goto Prev, 0, 1